Navigation Links
Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers
Date:1/7/2009

NASHVILLE, Tenn., Jan. 7 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of South Alabama, LLC, its seventh radiation oncology joint venture. ROSA of South Alabama is a joint venture among Gulf Coast Cancer Center - Gulf Shores, P.C., Monroeville Radiation - Oncology, P.C., and South Alabama Radiation Oncology, P.C., and ASA's subsidiary, Radiation Oncology Services of America, Inc. ROSA of South Alabama will own and operate four radiation oncology facilities in Gulf Shores, Brewton, Foley and Monroeville, Alabama.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO )

ROSA of South Alabama will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) in the facilities. The joint venture expects to build on Gulf Coast Cancer Centers' legacy of providing high-quality cancer care to the residents and visitors to the south Alabama region. The physicians currently serving patients at each facility will continue to provide physician services to patients being treated at the facilities. William Hixson, M.D. will serve as medical director for each of the facilities.

Dr. Hixson said, "When considering a partnership, we looked for a strong, growing company that not only brings business expertise to the table but, most importantly, also shares our passion for patient care. We look forward to working with ASA and ROSA as we continue our mission of providing superior care and service to the growing number of cancer patients in the Gulf Coast area."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are pleased to welcome the physicians and staff of Gulf Coast Cancer Centers to the ASA family. Dr. Hixson and his team are recognized in the industry as providers of high-quality cancer care through state-of-the-art technology, treatments and procedures. We look forward to working with them to continue to provide excellent service to cancer patients in the Gulf Coast region."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the formation of ROSA of South Alabama, ASA will own interests in and operate 17 radiation oncology centers and 44 dialysis centers in eleven states and the territory of Guam.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
2. B. Braun Medical Inc. Launches Ambulatory Surgical Center Website
3. Greenway Medical Technologies Leads Ambulatory Interoperability Exchange
4. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
5. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Chicago-Area Radiation Oncology Facility
6. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
7. Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg
8. Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
9. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
10. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
11. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: